Skip to main content
. 2021 Jul 7;74(3):334–340. doi: 10.5173/ceju.2021.3.0104

Table 3.

Histological data

Variable
Percutaneous renal tumor biopsy procedures (n = 84)
Pathology, n (%)
 Benign
 Malignant
 Non-diagnostic

14 (16.7)
53 (63.1)
17 (20.2)
Samples’ diagnosis, n (%)
 Clear cell carcinoma
 Clear and papillary cell carcinoma
 Papillary carcinoma
 Colic adenocarcinoma
 Oncocytoma
 Chromophobe carcinoma
 Undefined carcinoma
 Angiomyolipoma
 Melanoma
 Lymphoma
 Myeloma

30 (44.7)
1 (1.5)
9 (13.4)
2 (3.0)
10 (14.9)
3 (4.5)
3 (4.5)
4 (6.0)
1 (1.5)
3 (4.5)
1 (1.5)
Tumor grade, n (%)
 1
 2
 4

18 (45.0)
20 (50.0)
2 (5.0)
Patients undergoing renal surgery (n = 42)
Nephrectomy, n (%)
 Partial
 Total

26 (61.9)
16 (38.1)
Pathology, n (%)
 Benign
 Malignant

0 (0.0)
42 (100)
Histological diagnosis, n (%)
 Clear cell carcinoma
 Clear and papillary cell carcinoma
 Papillary carcinoma
 Colic adenocarcinoma
 Chromophobe carcinoma

25 (59.5)
2 (4.8)
9 (21.4)
1 (2.4)
5 (11.9)
Tumor grade, n (%)
 1
 2
 3
 4

9 (25.0)
21 (58.3)
4 (11.1)
2 (5.6)

n – number;

- repeated biopsies included;

- clear and papillary renal cell carcinoma